Brainsway Ltd share price today

(BWAY)

Brainsway Ltd share price is $10.12 & ₹857.47 as on 6 Dec 2024, 2.30 'hrs' IST

$10.12

▲

-0.3

(-2.88%)

Market is closed - opens 8 PM, 06 Dec 2024

View live Brainsway Ltd share price in Dollar and Rupees. Guide to invest in Brainsway Ltd from India. Also see the sentimental analysis on Indian investors investing in Brainsway Ltd. Get details on the Indian mutual funds that are investing in Brainsway Ltd. Get Analyst recommendations and forecasts along with all the Brainsway Ltd's financials.

Brainsway Ltd share price movements

$10.04
$10.39
$10.12
0.79%
Downside
Day's Volatility :3.32%
Upside
2.55%
$4.61
$10.98
$10.12
54.45%
Downside
52 Weeks Volatility :58.01%
Upside
7.83%

Brainsway Ltd Returns

Period	Brainsway Ltd	Index (Russel 2000)
3 Months	38.6%	0.0%
6 Months	53.88%	0.0%
1 Year	81.83%	0.0%
3 Years	24.65%	-18.1%

Brainsway Ltd Key Statistics

in dollars & INR

Previous Close	$10.42
Open	$10.4
Today's High	$10.385
Today's Low	$10.04
Market Capitalization	$185.4M
Today's Volume	$74.8K
52 Week High	$10.98
52 Week Low	$4.61
Revenue TTM	$36.4M
EBITDA	$1.8M
Earnings Per Share (EPS)	$0.08
PE Ratio	123.38
Profit Margin	1.67%
Quarterly Earnings Growth YOY	0.0%
Return On Equity TTM	1.44%

How to invest in Brainsway Ltd from India?

It is very easy for Indian residents to invest directly in Brainsway Ltd from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Brainsway Ltd stock in both rupees (INR) and dollars (USD). Search for Brainsway Ltd or BWAY on INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Brainsway Ltd or Rupee/ Dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Brainsway Ltd shares which would translate to 0.084 fractional shares of Brainsway Ltd as of today. Learn more about fractional investing here.

Indians via INDmoney can now also, easily transfer and add their money to the US stocks account via INDmoney App. Click here for step by step process for the same

Indian investors sentiment towards Brainsway Ltd

-32%

Period: Sep 6, 2024 to Dec 5, 2024. Change in 30 Days versus previous period

Search volume for Brainsway Ltd on INDmoney from India has reduced in the last 30 days as on Dec 6, 2024. -32% less investors are searching Brainsway Ltd in the last 30 days versus the previous period.

Global Institutional Holdings in Brainsway Ltd

Masters Capital Management LLC
4.79%
Renaissance Technologies Corp
1.92%
Essex Investment Management Company, LLC
1.85%
Dafna Capital Management LLC
1.34%
Phoenix Financial Ltd
1.28%
Cresset Asset Management, LLC
0.84%

Analyst Recommendation on Brainsway Ltd

Buy

85%Buy

14%Hold

0%Sell

Based on 7 Wall street analysts offering stock ratings for Brainsway Ltd(by analysts ranked 0 to 5 stars)

Based on 7 analyst

Current
1M Ago
3M Ago

Buy

Hold

Sell

Analyst Forecast on Brainsway Ltd

What analysts predicted

Upside of 35.62%

Current:

$10.12

Target:

$13.73

Insights on Brainsway Ltd

Increasing Revenue
Revenue is up for the last 9 quarters, 5.16M → 10.50M (in $), with an average increase of 8.4% per quarter
Increasing Net Profit
Netprofit is up for the last 3 quarters, 111.0K → 662.0K (in $), with an average increase of 45.4% per quarter
Vs BSX
In the last 1 year, Boston Scientific Corp. has given 64.8% return, outperforming this stock by 4.3%
Vs BSX
In the last 3 years, Boston Scientific Corp. has given 129.2% return, outperforming this stock by 89.4%

Brainsway Ltd Financials in INR & Dollars

	FY18	Y/Y Change
Revenue	$16.4M	↑ 47.12%
Net Income	$-6.5M	↓ 8.15%
Net Profit Margin	-39.51%	↑ 23.78%

	FY19	Y/Y Change
Revenue	$23.1M	↑ 40.89%
Net Income	$-10.3M	↑ 59.41%
Net Profit Margin	-44.71%	↓ 5.2%

	FY20	Y/Y Change
Revenue	$22.1M	↓ 4.52%
Net Income	$-5.4M	↓ 47.86%
Net Profit Margin	-24.41%	↑ 20.3%

	FY21	Y/Y Change
Revenue	$29.7M	↑ 34.46%
Net Income	$-6.5M	↑ 20.0%
Net Profit Margin	-21.79%	↑ 2.62%

	FY22	Y/Y Change
Revenue	$27.2M	↓ 8.36%
Net Income	$-13.3M	↑ 106.58%
Net Profit Margin	-49.12%	↓ 27.33%

	FY23	Y/Y Change
Revenue	$31.8M	↑ 16.96%
Net Income	$-4.2M	↓ 68.56%
Net Profit Margin	-13.2%	↑ 35.92%

	Q2 FY23	Q/Q Change
Revenue	$7.8M	↑ 18.17%
Net Income	$-1.7M	↓ 31.59%
Net Profit Margin	-21.24%	↑ 15.45%

	Q3 FY23	Q/Q Change
Revenue	$8.3M	↑ 6.04%
Net Income	$-230.0K	↓ 86.17%
Net Profit Margin	-2.77%	↑ 18.47%

	Q4 FY23	Q/Q Change
Revenue	$9.0M	↑ 8.76%
Net Income	$127.0K	↓ 155.22%
Net Profit Margin	1.41%	↑ 4.18%

	Q1 FY24	Q/Q Change
Revenue	$9.1M	↑ 0.73%
Net Income	$111.0K	↓ 12.6%
Net Profit Margin	1.22%	↓ 0.19%

	Q2 FY24	Q/Q Change
Revenue	$10.0M	↑ 10.01%
Net Income	$600.0K	↑ 440.54%
Net Profit Margin	6.0%	↑ 4.78%

	Q3 FY24	Q/Q Change
Revenue	$10.5M	↑ 4.97%
Net Income	$662.0K	↑ 10.33%
Net Profit Margin	6.3%	↑ 0.3%

	FY18	Y/Y Change
Total Assets	$23.6M	↓ 12.68%
Total Liabilities	$16.7M	↑ 16.36%

	FY19	Y/Y Change
Total Assets	$38.7M	↑ 64.12%
Total Liabilities	$14.5M	↓ 12.82%

	FY20	Y/Y Change
Total Assets	$34.0M	↓ 12.2%
Total Liabilities	$14.4M	↓ 0.96%

	FY21	Y/Y Change
Total Assets	$75.7M	↑ 122.67%
Total Liabilities	$18.4M	↑ 28.04%

	FY22	Y/Y Change
Total Assets	$64.5M	↓ 14.86%
Total Liabilities	$19.1M	↑ 3.65%

	FY23	Y/Y Change
Total Assets	$63.0M	↓ 2.33%
Total Liabilities	$21.4M	↑ 12.11%

	Q2 FY23	Q/Q Change
Total Assets	$59.2M	↓ 4.37%
Total Liabilities	$17.9M	↓ 6.02%

	Q3 FY23	Q/Q Change
Total Assets	$59.8M	↑ 0.89%
Total Liabilities	$18.6M	↑ 3.71%

	Q4 FY23	Q/Q Change
Total Assets	$63.0M	↑ 5.35%
Total Liabilities	$15.3M	↓ 17.47%

	Q1 FY24	Q/Q Change
Total Assets	$65.1M	↑ 3.45%
Total Liabilities	$17.3M	↑ 13.0%

	Q2 FY24	Q/Q Change
Total Assets	$65.6M	↑ 0.75%
Total Liabilities	$22.7M	↑ 30.89%

	Q3 FY24	Q/Q Change
Total Assets	$72.1M	↑ 9.86%
Total Liabilities	$28.1M	↑ 23.93%

	FY18	Y/Y Change
Operating Cash Flow	$-3.8M	↑ 8.83%
Investing Cash Flow	$-1.1M	↓ 53.65%
Financing Cash Flow	$-265.0K	↓ 102.39%

	FY19	Y/Y Change
Operating Cash Flow	$-7.2M	↑ 92.0%
Investing Cash Flow	$-2.4M	↑ 115.32%
Financing Cash Flow	$22.5M	↓ 8580.75%

	FY20	Y/Y Change
Operating Cash Flow	$-1.4M	↓ 80.18%
Investing Cash Flow	$-2.5M	↑ 0.78%
Financing Cash Flow	$-1.0M	↓ 104.58%

	FY21	Y/Y Change
Operating Cash Flow	$884.0K	↓ 161.56%
Investing Cash Flow	$-42.2M	↑ 1612.62%
Financing Cash Flow	$41.5M	↓ 4130.68%

	FY22	Y/Y Change
Operating Cash Flow	$-9.8M	↓ 1203.96%
Investing Cash Flow	$42.2M	↓ 199.89%
Financing Cash Flow	$-1.5M	↓ 103.73%

	Q2 FY23	Q/Q Change
Operating Cash Flow	$995.0K	↓ 128.1%
Investing Cash Flow	$-1.5M	↓ 2460.94%
Financing Cash Flow	$-377.0K	↑ 471.21%

Brainsway Ltd Technicals Summary

Sell

Neutral

Buy

Brainsway Ltd is currently in a favorable trading position ( BUY ) according to technical analysis indicators.

Brainsway Ltd Vs Peers

Company Name	1 Month	6 Month	1 Year	3 Years	5 Years
Brainsway Ltd	-4.07%	53.88%	81.83%	24.65%	-7.73%
Stryker Corporation	5.35%	11.54%	34.64%	49.54%	94.43%
Boston Scientific Corp.	5.72%	17.27%	64.33%	118.43%	106.89%
Edwards Lifesciences Corp.	5.76%	-19.98%	3.33%	-38.95%	-9.69%
Abbott Laboratories	-0.78%	8.58%	12.26%	-11.79%	39.28%
Medtronic Plc	-3.5%	2.94%	8.79%	-22.92%	-22.13%

Company Name	P/E Ratio	P/B Ratio	PEG Ratio	EPS	ROE	ROA	Div Yield	BVPS
Brainsway Ltd	123.38	123.38	NA	0.06	0.01	0.01	NA	1.25
Stryker Corporation	42.03	42.03	2.74	12.06	0.19	0.07	0.01	52.86
Boston Scientific Corp.	74.93	74.93	1.64	2.46	0.09	0.05	NA	14.05
Edwards Lifesciences Corp.	27.55	27.55	6.52	2.53	0.19	0.11	NA	16.18
Abbott Laboratories	36.1	36.1	2.31	4.68	0.15	0.06	0.02	22.94
Medtronic Plc	26.38	26.38	1.56	5.2	0.08	0.04	0.03	38.29

Company Name	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin
Brainsway Ltd	Buy	$185.4M	-7.73%	123.38	1.67%
Stryker Corporation	Buy	$149.5B	94.43%	42.03	16.34%
Boston Scientific Corp.	Buy	$133.7B	106.89%	74.93	11.26%
Edwards Lifesciences Corp.	Buy	$42.5B	-9.69%	27.55	65.86%
Abbott Laboratories	Buy	$206.3B	39.28%	36.1	13.99%
Medtronic Plc	Buy	$110.6B	-22.13%	26.38	12.06%

About Brainsway Ltd

brainsway is a leading global neurmodulation company with headquarters in jerusalem and the us. our patented breakthrough technology has already treated over 10,000 patients, and has helped usher in a new era in brain disorder treatment. a non-invasive, yet highly effective solution for brain disorders, brainsway has helped thousands of patients across the world, from the unites states to europe to south america, and has the potential to make a difference in the well-being and health of millions of patients worldwide. brainsway's technology offers a much needed alternative for millions of patients from a bleak cycle of insufficiently effective treatments and unpleasant side effects. brainsway's treatment has fda approval for treating patients with major depressive disorder*. the technology is safe, with no systemic or long-term side effects, in addition to being highly convenient, requiring only brief daily sessions over a few weeks. in addition to being used to treat depression daily

Organization	Brainsway Ltd
Employees	134
CEO	Mr. Hadar Levy
Industry	Medical Specialties

Management People of Brainsway Ltd

Name	Title
Mr. Hadar Levy	Chief Executive Officer
Mr. Avner Hagai	Founder & Director
Prof. Abraham Zangen	Co-Founder, Member of Scientific Advisory Board & Director
Dr. Yiftach Roth Ph.D.	Founder & Chief Scientific Officer
Mr. Ido Marom	Chief Financial Officer
Mr. Gilead Moiseyev	Chief Technology Officer
Mr. Menachem C. Klein Esq.	VP, General Counsel & Corporate Secretary
Mr. Ross Mitchell	Vice President of Global Marketing
Ms. Hillegonda Groen	Vice President of International Sales
Dr. Richard A. Bermudes M.D.	Chief Medical Officer

Important FAQs about investing in Brainsway Ltd from India :

What is Brainsway Ltd share price today?

Brainsway Ltd (BWAY) share price today is $10.12.

Can Indians buy Brainsway Ltd shares?

Yes, Indians can invest in the Brainsway Ltd (BWAY) from India.

With INDmoney, you can buy Brainsway Ltd at 0 brokerage. The step-by-step process is as follows:

Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
Once funds are transferred successfully, you can buy Brainsway Ltd at zero transaction cost.

How can I buy Brainsway Ltd shares from India?

It is very easy to buy Brainsway Ltd from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Brainsway Ltd be purchased?

Yes, you can buy fractional shares of Brainsway Ltd with INDmoney app.

What are the documents required to start investing in Brainsway Ltd stocks?

To start investing in Brainsway Ltd, You will need the following documents:

Proof of Identification (PAN, Aadhaar etc)
Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.